NCT02874859View on ClinicalTrials.gov

Intravitreal Aflibercept InjectiOn in Vitrectomized Eyes for Treatment of Diabetic Macular Edema

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

November 9, 2016

Primary Completion Date

August 19, 2020

Study Completion Date

August 19, 2020

Conditions
Diabetic Macular Edema
Trial Locations (8)

33000

Dr DOMINGUEZ, Bordeaux

44300

Dr Franck BECQUET, Nantes

59160

Tran Thi Ha Chau, Lomme

69004

Pr KODJIKIAN, Lyon

75010

Bénédicte DUPAS, Paris

76100

Dr UZZAN, Rouen

80000

Pr MILAZZO Solange, Amiens

06001

Stéphanie BAILLIF, Nice

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Lille Catholic University

OTHER

NCT02874859 - Intravitreal Aflibercept InjectiOn in Vitrectomized Eyes for Treatment of Diabetic Macular Edema | Biotech Hunter | Biotech Hunter